A61P 15/10
Drugs for genital or sexual disorders: for impotence
Official title: for impotence
A61P15/10 (Drugs for genital or sexual disorders: for impotence) appears on 2,977 US grants and 4,637 published applications in this corpus.
Search patents in A61P- Granted patents
- 2,977
- Published applications
- 4,637
- Assignees
- 1,272
- Inventors
- 7,447
- Latest grant
- 18 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1991 | 1 | 0 |
| 1992 | 1 | 0 |
| 1993 | 2 | 0 |
| 1994 | 2 | 0 |
| 1995 | 5 | 0 |
| 1996 | 6 | 0 |
| 1997 | 9 | 0 |
| 1998 | 3 | 0 |
| 1999 | 32 | 0 |
| 2000 | 54 | 0 |
| 2001 | 87 | 25 |
| 2002 | 101 | 135 |
| 2003 | 115 | 237 |
| 2004 | 109 | 328 |
| 2005 | 114 | 234 |
| 2006 | 150 | 250 |
| 2007 | 102 | 297 |
| 2008 | 130 | 311 |
| 2009 | 152 | 385 |
| 2010 | 190 | 467 |
| 2011 | 204 | 296 |
| 2012 | 219 | 226 |
| 2013 | 217 | 204 |
| 2014 | 207 | 221 |
| 2015 | 139 | 173 |
| 2016 | 114 | 134 |
| 2017 | 113 | 106 |
| 2018 | 81 | 111 |
| 2019 | 68 | 94 |
| 2020 | 73 | 91 |
| 2021 | 50 | 75 |
| 2022 | 35 | 54 |
| 2023 | 26 | 44 |
| 2024 | 27 | 69 |
| 2025 | 26 | 44 |
| 2026 | 13 | 26 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Method of using a needle assisted injection device having reduced trigger force18 Aug 2026US 12,708,710 B2Antares Pharma, Inc.
- Crystalline form III of melanocortin receptor agonist compound and preparation method therefor11 Aug 2026US 12,703,683 B2LG Chem.Ltd.
- Diacylglycerol acyl transferase 2 inhibitors11 Aug 2026US 12,703,696 B2Pfizer Inc.
- Optimized bio-synchronous bioactive agent delivery system9 Jun 2026US 12,649,029 B2Morningside Venture Investments Limited
- Sugar chain-related gene and use thereof26 May 2026US 12,637,675 B2Stelic Institute & Co.
- Compound for treatment of female sexual dysfunction10 Sep 2026US 2026/0263443 A1Initiator Pharma A/S
- Compositions for treating a subject from sexual dysfunction27 Aug 2026US 2026/0248810 A1
- Inhalable hormone receptor agonist formulations13 Aug 2026US 2026/0232694 A1Pinata Holdings Inc.
- Composition of Ginseng, Cistanche deserticola, and Polygonatum sibiricum with Ability to Improve Erectile Dysfunction Caused by Aging, and Preparation Method Therefor13 Aug 2026US 2026/0232747 A1Jiangnan University
- Method of treating raynaud's conditions or erectile dysfunction6 Aug 2026US 2026/0224653 A1Bioharvest Ltd.
Most cited
By later US patents
- Solid carriers for improved delivery of active ingredients in pharmaceutical compositions930US 6,248,363 B1Lipocine Inc. · 2001
- Solid carriers for improved delivery of active ingredients in pharmaceutical compositions684US 6,923,988 B2Lipocine Inc. · 2005
- Solid carriers for improved delivery of hydrophobic active ingredients in pharmaceutical compositions616US 6,569,463 B2Lipocine Inc. · 2003
- Dermal penetration enhancers and drug delivery systems involving same297US 6,299,900 B1Monash University · 2001
- Albumin fusion proteins comprising GLP-1 polypeptides198US 7,141,547 B2Human Genome Sciences, Inc. · 2006